Skip to main content
CAMP $5.44 +20.89%
CAMP logo

CAMP · Camp4 Therapeutics Corp

Track CAMP — free
$5.44 +0.94 (+20.89%) At close · Aug 14
Market Cap
$341.38M
Shares
62.75M
All earnings calls

Earnings call · FY2024 Q1

Camp4 Therapeutics Corp Q1 FY2024 Earnings Call

Camp4 Therapeutics Corp Q1 FY2024 Earnings Call

Concluded Mar 31, 2024
Mar 31, 2024 61 turns
Period
FY2024 Q1
Runtime
Sources
1 artifact

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.

Subscription model conversion and recurring revenue 28 TSP/channel customer inventory correction 22 Competitive landscape and share 21 Cost management and profitability 21 Vision solution / dash camera product 13 BMW and consumer automotive business 5

Management tone

Balanced

Net tone +5 · moderate hedging

Grounding quotes
  • “Despite missing the low-end of guidance, the team's focus on cost efficiencies produced gross margin growth of 280 basis points and generated over $6 million of adjusted EBITDA.”
  • “demand from our telematics service providers, or TSPs, and channel customers demonstrated some softness in the quarter as they adjusted their order volumes in inventory strategies to better align with a more normalized shipping environment.”
  • “Overall, the CalAmp team is more focused than ever on driving top-line revenue with a leaner and more efficient cost structure to increase the profitability of the company.”
  • “We will not be answering any questions on this topic today.”

Forward guidance

2 guided metrics

Management's latest ranges and targets are included below.

Research coverage

1 live source

Switch sources without leaving this page or losing your listening position.

Revenue $0
Diluted EPS -$26.57
Net income -$12.46M

Research materials

Open the source you need; every reader stays inside this workspace.

Guidance from the call

Stated verbally and extracted from the transcript.

Metric Guided
Revenue
Q2 FY '24
$67M – $73M
Adjusted EBITDA
Q2 FY '24
$5M – $9M
Full-screen source Call document